Moreover, our data demonstrated that lower expression of C-KIT was found in patients with low-risk prognostic factors, and its overexpression associated significantly with karyotypes of favorable prognosis [AML with t(8;21) and (inv-16)]. This evidence concerns the gene KIT and acute myeloid leukemia.